Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.71B
Enterprise Value2.7B
P/E Ratio42.74
PEG Ratio0.32
Price/Sales Ratio2.41
Price/Book Ratio1.94
Enterprise/Revenue2.43
Enterprise/EBITDA29.08

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue911.95M
Revenue/Share7.09
Gross Profit295.88M
EBITDA74.96M
Net Income48.66M
Diluted EPS0.36

Balance Sheet

Total Cash583M
Total Cash/Share4.31
Total Debt316.39M
Total Debt/Equity0.27
Current Ratio2.39
Book Value Per Share8.79

Price History

52-Week Change-11.5
52-Week High34.69
52-Week Low16.35
Moving Average 50 Days20.01
Moving Average 200 Days21.68

Statistics

Average Volume2.34M
Shares Outstanding135.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield0.88
Payout Ratio0.38
Last Split FactorN/A
Last Split DateN/A
AD